

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 4.82494105 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.82494105 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.82494105 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.82494105 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.82494105 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.82494105 |
| 7 | glycolipid catabolic process (GO:0019377) | 4.78851841 |
| 8 | oligosaccharide catabolic process (GO:0009313) | 4.51601069 |
| 9 | microglial cell activation (GO:0001774) | 4.49886154 |
| 10 | regulation of mononuclear cell migration (GO:0071675) | 4.25602787 |
| 11 | barbed-end actin filament capping (GO:0051016) | 4.14999673 |
| 12 | ceramide catabolic process (GO:0046514) | 4.14434303 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.08477712 |
| 14 | amino sugar catabolic process (GO:0046348) | 4.01047232 |
| 15 | membrane lipid catabolic process (GO:0046466) | 3.74688256 |
| 16 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.74221493 |
| 17 | sphingolipid catabolic process (GO:0030149) | 3.69146071 |
| 18 | apoptotic cell clearance (GO:0043277) | 3.51372023 |
| 19 | regulation of macrophage chemotaxis (GO:0010758) | 3.50065547 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 3.45117561 |
| 21 | response to thyroid hormone (GO:0097066) | 3.43686423 |
| 22 | adhesion of symbiont to host cell (GO:0044650) | 3.41923189 |
| 23 | virion attachment to host cell (GO:0019062) | 3.41923189 |
| 24 | response to peptidoglycan (GO:0032494) | 3.38916150 |
| 25 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.38236593 |
| 26 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.38236593 |
| 27 | protein localization to endosome (GO:0036010) | 3.28664499 |
| 28 | adhesion of symbiont to host (GO:0044406) | 3.25753962 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.21532864 |
| 30 | response to host immune response (GO:0052572) | 3.21532864 |
| 31 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.18220951 |
| 32 | complement activation, alternative pathway (GO:0006957) | 3.14348761 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.12232293 |
| 34 | N-acetylneuraminate metabolic process (GO:0006054) | 3.10104050 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.08315830 |
| 36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.01390688 |
| 37 | response to host (GO:0075136) | 2.95945374 |
| 38 | response to host defenses (GO:0052200) | 2.95945374 |
| 39 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95945374 |
| 40 | low-density lipoprotein particle clearance (GO:0034383) | 2.94313284 |
| 41 | pinocytosis (GO:0006907) | 2.93039230 |
| 42 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.91653950 |
| 43 | positive regulation of cholesterol efflux (GO:0010875) | 2.91016092 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 2.89980759 |
| 45 | macrophage activation (GO:0042116) | 2.89786425 |
| 46 | angiotensin maturation (GO:0002003) | 2.89108693 |
| 47 | amyloid precursor protein catabolic process (GO:0042987) | 2.87735424 |
| 48 | mannose metabolic process (GO:0006013) | 2.86300353 |
| 49 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.84577775 |
| 50 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.83777409 |
| 51 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.82088053 |
| 52 | protein carboxylation (GO:0018214) | 2.82088053 |
| 53 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.81587984 |
| 54 | peptide catabolic process (GO:0043171) | 2.80721746 |
| 55 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.78929840 |
| 56 | L-phenylalanine catabolic process (GO:0006559) | 2.78929840 |
| 57 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.76666357 |
| 58 | regulation of vitamin metabolic process (GO:0030656) | 2.76568474 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 2.75508404 |
| 60 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.73958384 |
| 61 | regulation of podosome assembly (GO:0071801) | 2.73698141 |
| 62 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.72449256 |
| 63 | eosinophil chemotaxis (GO:0048245) | 2.71833252 |
| 64 | immunoglobulin mediated immune response (GO:0016064) | 2.68639380 |
| 65 | keratan sulfate catabolic process (GO:0042340) | 2.63605397 |
| 66 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.63472430 |
| 67 | decidualization (GO:0046697) | 2.63007793 |
| 68 | alpha-linolenic acid metabolic process (GO:0036109) | 2.62826413 |
| 69 | hyaluronan catabolic process (GO:0030214) | 2.62732929 |
| 70 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.62163780 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 2.61839877 |
| 72 | regulation of superoxide anion generation (GO:0032928) | 2.61366181 |
| 73 | cholesterol efflux (GO:0033344) | 2.60955013 |
| 74 | cellular response to cadmium ion (GO:0071276) | 2.57683513 |
| 75 | low-density lipoprotein particle remodeling (GO:0034374) | 2.56601664 |
| 76 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.56479422 |
| 77 | positive regulation of extracellular matrix organization (GO:1903055) | 2.55871959 |
| 78 | monocyte chemotaxis (GO:0002548) | 2.55795695 |
| 79 | reverse cholesterol transport (GO:0043691) | 2.55460709 |
| 80 | COPI coating of Golgi vesicle (GO:0048205) | 2.54436640 |
| 81 | Golgi transport vesicle coating (GO:0048200) | 2.54436640 |
| 82 | glial cell migration (GO:0008347) | 2.54072798 |
| 83 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.52179748 |
| 84 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.51837675 |
| 85 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.51039356 |
| 86 | regulation of protein activation cascade (GO:2000257) | 2.50366440 |
| 87 | positive regulation of leukocyte degranulation (GO:0043302) | 2.50197125 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 2.47085611 |
| 89 | high-density lipoprotein particle remodeling (GO:0034375) | 2.46992984 |
| 90 | regulation of cholesterol esterification (GO:0010872) | 2.46865252 |
| 91 | L-phenylalanine metabolic process (GO:0006558) | 2.46774232 |
| 92 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.46774232 |
| 93 | gamma-aminobutyric acid transport (GO:0015812) | 2.46668286 |
| 94 | positive regulation of sterol transport (GO:0032373) | 2.46359234 |
| 95 | positive regulation of cholesterol transport (GO:0032376) | 2.46359234 |
| 96 | phospholipid efflux (GO:0033700) | 2.46192467 |
| 97 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.46014281 |
| 98 | protein retention in ER lumen (GO:0006621) | 2.45629459 |
| 99 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.44304098 |
| 100 | regulation of apoptotic cell clearance (GO:2000425) | 2.44141297 |
| 101 | protein-lipid complex remodeling (GO:0034368) | 2.41906659 |
| 102 | macromolecular complex remodeling (GO:0034367) | 2.41906659 |
| 103 | plasma lipoprotein particle remodeling (GO:0034369) | 2.41906659 |
| 104 | detection of molecule of bacterial origin (GO:0032490) | 2.41143912 |
| 105 | aromatic amino acid family catabolic process (GO:0009074) | 2.41001706 |
| 106 | regulation of complement activation (GO:0030449) | 2.40925001 |
| 107 | negative regulation of cholesterol transport (GO:0032375) | 2.40037735 |
| 108 | negative regulation of sterol transport (GO:0032372) | 2.40037735 |
| 109 | vitamin D metabolic process (GO:0042359) | 2.39568101 |
| 110 | positive regulation of antigen processing and presentation (GO:0002579) | 2.38550365 |
| 111 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.38205854 |
| 112 | eosinophil migration (GO:0072677) | 2.38015599 |
| 113 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.37988123 |
| 114 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.37761834 |
| 115 | lipoprotein transport (GO:0042953) | 2.36787220 |
| 116 | regulation of monocyte chemotaxis (GO:0090025) | 2.35588012 |
| 117 | cellular response to arsenic-containing substance (GO:0071243) | 2.35546619 |
| 118 | urea cycle (GO:0000050) | 2.35417061 |
| 119 | urea metabolic process (GO:0019627) | 2.35417061 |
| 120 | macrophage differentiation (GO:0030225) | 2.35378430 |
| 121 | glucose 6-phosphate metabolic process (GO:0051156) | 2.34354957 |
| 122 | bile acid biosynthetic process (GO:0006699) | 2.33346989 |
| 123 | phospholipid homeostasis (GO:0055091) | 2.33024064 |
| 124 | L-amino acid import (GO:0043092) | 2.32756924 |
| 125 | positive regulation of interferon-alpha production (GO:0032727) | 2.32717753 |
| 126 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.31710969 |
| 127 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.30574079 |
| 128 | I-kappaB phosphorylation (GO:0007252) | 2.28636934 |
| 129 | macroautophagy (GO:0016236) | 2.28438166 |
| 130 | regulation of early endosome to late endosome transport (GO:2000641) | 2.27443079 |
| 131 | alanine transport (GO:0032328) | 2.24927106 |
| 132 | regulation of cholesterol storage (GO:0010885) | 2.23937966 |
| 133 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.22185071 |
| 134 | adenosine receptor signaling pathway (GO:0001973) | 2.21314081 |
| 135 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.21028137 |
| 136 | positive regulation of lipid catabolic process (GO:0050996) | 2.20425939 |
| 137 | regulation of interferon-alpha production (GO:0032647) | 2.18453644 |
| 138 | bile acid metabolic process (GO:0008206) | 2.13133126 |
| 139 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.12259731 |
| 140 | nitrogen cycle metabolic process (GO:0071941) | 2.11127279 |
| 141 | tryptophan metabolic process (GO:0006568) | 2.10764271 |
| 142 | indole-containing compound catabolic process (GO:0042436) | 2.10429424 |
| 143 | indolalkylamine catabolic process (GO:0046218) | 2.10429424 |
| 144 | tryptophan catabolic process (GO:0006569) | 2.10429424 |
| 145 | phagosome maturation (GO:0090382) | 2.08724857 |
| 146 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.07716501 |
| 147 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.06326063 |
| 148 | cofactor catabolic process (GO:0051187) | 2.06276329 |
| 149 | myeloid cell activation involved in immune response (GO:0002275) | 2.05440363 |
| 150 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.04917324 |
| 151 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.04515872 |
| 152 | neutrophil activation involved in immune response (GO:0002283) | 2.04489879 |
| 153 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.03930534 |
| 154 | plasma lipoprotein particle organization (GO:0071827) | 2.03779949 |
| 155 | synaptic vesicle maturation (GO:0016188) | 2.03764950 |
| 156 | negative regulation of fibrinolysis (GO:0051918) | 2.03688601 |
| 157 | T-helper 1 type immune response (GO:0042088) | 2.03468452 |
| 158 | regulation of beta-amyloid formation (GO:1902003) | 2.03293320 |
| 159 | tyrosine metabolic process (GO:0006570) | 2.02558453 |
| 160 | complement activation (GO:0006956) | 2.01836293 |
| 161 | respiratory burst (GO:0045730) | 2.01429001 |
| 162 | homocysteine metabolic process (GO:0050667) | 2.00616103 |
| 163 | regulation of fibrinolysis (GO:0051917) | 2.00515942 |
| 164 | regulation of cellular amide metabolic process (GO:0034248) | 1.99389348 |
| 165 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 1.97886626 |
| 166 | kynurenine metabolic process (GO:0070189) | 1.97504996 |
| 167 | glutamate metabolic process (GO:0006536) | 1.97394422 |
| 168 | regulation of triglyceride catabolic process (GO:0010896) | 1.97331812 |
| 169 | nucleobase catabolic process (GO:0046113) | 1.96578307 |
| 170 | basic amino acid transport (GO:0015802) | 1.95890034 |
| 171 | protein-lipid complex subunit organization (GO:0071825) | 1.95378398 |
| 172 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 1.95124141 |
| 173 | cellular response to thyroid hormone stimulus (GO:0097067) | 1.94656387 |
| 174 | glycosphingolipid catabolic process (GO:0046479) | 1.94374820 |
| 175 | plasma lipoprotein particle assembly (GO:0034377) | 1.93567253 |
| 176 | amino acid import (GO:0043090) | 1.93350066 |
| 177 | cellular modified amino acid catabolic process (GO:0042219) | 1.92220026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.81724402 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.86107911 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.77405322 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.77199362 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.69913175 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.46909712 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42496275 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.37755753 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.28015927 |
| 10 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.24446037 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24114654 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.19609470 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.10113881 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.98421918 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92415048 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89020680 |
| 17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.88589643 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.87611654 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.86435217 |
| 20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.84855067 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.83039620 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79740183 |
| 23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.79256900 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77528792 |
| 25 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.76946758 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76592017 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.72727712 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.71275110 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70239233 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.67066272 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66658564 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.66493672 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66011325 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65814017 |
| 35 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63939253 |
| 36 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.63340430 |
| 37 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61175859 |
| 38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60789235 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58152342 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58055354 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57170764 |
| 42 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.56536580 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.56536580 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.56337175 |
| 45 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.56319636 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53965923 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53857166 |
| 48 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48253730 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47283601 |
| 50 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.47174015 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46774797 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46311977 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46100053 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.45145948 |
| 55 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.42351648 |
| 56 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41937618 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41567275 |
| 58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40966108 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.40883226 |
| 60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40647522 |
| 61 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.39582877 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39545213 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38674579 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37107568 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37037354 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36619031 |
| 67 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35852134 |
| 68 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35717262 |
| 69 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35469028 |
| 70 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.34107379 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.33168564 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.33168564 |
| 73 | KDM2B_26808549_Chip-Seq_K562_Human | 1.32231584 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31824656 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31491157 |
| 76 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.28199897 |
| 77 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.26451404 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26128065 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25782929 |
| 80 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.24282173 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24181561 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.24132121 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24049357 |
| 84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23201985 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21831004 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21818163 |
| 87 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21516363 |
| 88 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21283533 |
| 89 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21257213 |
| 90 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20135088 |
| 91 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19952465 |
| 92 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19936687 |
| 93 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19475731 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 1.19043519 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18672366 |
| 96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18547095 |
| 97 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18293650 |
| 98 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18239457 |
| 99 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18222036 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18154640 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17157473 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17146413 |
| 103 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.17092316 |
| 104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16198574 |
| 105 | MAF_26560356_Chip-Seq_TH1_Human | 1.14111600 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13244352 |
| 107 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12673990 |
| 108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12458992 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11771947 |
| 110 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11225745 |
| 111 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10762006 |
| 112 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09761697 |
| 113 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.09560225 |
| 114 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09516190 |
| 115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09384996 |
| 116 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09130384 |
| 117 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08912531 |
| 118 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08269279 |
| 119 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08060724 |
| 120 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07946378 |
| 121 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07653749 |
| 122 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06820055 |
| 123 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.06554389 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06308521 |
| 125 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05962930 |
| 126 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05076570 |
| 127 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04795491 |
| 128 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.04552187 |
| 129 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04020540 |
| 130 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03535035 |
| 131 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.02349538 |
| 132 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01860706 |
| 133 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01734139 |
| 134 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.01319990 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00836135 |
| 136 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00579635 |
| 137 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00544160 |
| 138 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00213812 |
| 139 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99082909 |
| 140 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98940862 |
| 141 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98422386 |
| 142 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97052006 |
| 143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95991539 |
| 144 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95917340 |
| 145 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95415545 |
| 146 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95383962 |
| 147 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95336730 |
| 148 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95194292 |
| 149 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95101914 |
| 150 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.95064137 |
| 151 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94940969 |
| 152 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94354361 |
| 153 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94059008 |
| 154 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93890525 |
| 155 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93624753 |
| 156 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92823057 |
| 157 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92787026 |
| 158 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91875863 |
| 159 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91618715 |
| 160 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.91560734 |
| 161 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91245656 |
| 162 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89578211 |
| 163 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.88311671 |
| 164 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87896393 |
| 165 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87839966 |
| 166 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87751295 |
| 167 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.86129313 |
| 168 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85863124 |
| 169 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85786067 |
| 170 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85684947 |
| 171 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83201253 |
| 172 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.82900059 |
| 173 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.82723649 |
| 174 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81763257 |
| 175 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80229655 |
| 176 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80180692 |
| 177 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79871158 |
| 178 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79760667 |
| 179 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78401357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.86538584 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 3.13056578 |
| 3 | * MP0005058_abnormal_lysosome_morphology | 3.02142876 |
| 4 | MP0005360_urolithiasis | 3.01141504 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.91840050 |
| 6 | MP0009840_abnormal_foam_cell | 2.80989147 |
| 7 | MP0003690_abnormal_glial_cell | 2.73424500 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.65086278 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.55963068 |
| 10 | MP0005365_abnormal_bile_salt | 2.51307545 |
| 11 | MP0006082_CNS_inflammation | 2.40584854 |
| 12 | MP0000604_amyloidosis | 2.35272631 |
| 13 | MP0003252_abnormal_bile_duct | 2.19162004 |
| 14 | MP0005451_abnormal_body_composition | 2.18085236 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.12805885 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.09003611 |
| 17 | MP0004858_abnormal_nervous_system | 2.05150343 |
| 18 | MP0003195_calcinosis | 2.03404640 |
| 19 | MP0003075_altered_response_to | 1.92264282 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 1.87260529 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.87080463 |
| 22 | MP0001984_abnormal_olfaction | 1.86933252 |
| 23 | MP0003303_peritoneal_inflammation | 1.85431304 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.83303745 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.69229059 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 1.68212817 |
| 27 | * MP0002064_seizures | 1.67687508 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.65170809 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.64696351 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.63620967 |
| 31 | MP0009278_abnormal_bone_marrow | 1.60508627 |
| 32 | MP0005083_abnormal_biliary_tract | 1.59979648 |
| 33 | MP0002419_abnormal_innate_immunity | 1.58428737 |
| 34 | MP0003329_amyloid_beta_deposits | 1.55699392 |
| 35 | MP0005167_abnormal_blood-brain_barrier | 1.53146519 |
| 36 | MP0000858_altered_metastatic_potential | 1.48974784 |
| 37 | MP0001853_heart_inflammation | 1.48366886 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.47440028 |
| 39 | MP0003724_increased_susceptibility_to | 1.46495857 |
| 40 | MP0009745_abnormal_behavioral_response | 1.45159261 |
| 41 | MP0003436_decreased_susceptibility_to | 1.44054182 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.43629625 |
| 43 | MP0009046_muscle_twitch | 1.42920929 |
| 44 | MP0000685_abnormal_immune_system | 1.38675466 |
| 45 | MP0003448_altered_tumor_morphology | 1.37426468 |
| 46 | MP0002063_abnormal_learning/memory/cond | 1.36952377 |
| 47 | MP0008260_abnormal_autophagy | 1.36222840 |
| 48 | MP0004510_myositis | 1.36141207 |
| 49 | MP0003880_abnormal_central_pattern | 1.34991448 |
| 50 | MP0002736_abnormal_nociception_after | 1.34582518 |
| 51 | MP0009764_decreased_sensitivity_to | 1.33880938 |
| 52 | MP0002090_abnormal_vision | 1.33310706 |
| 53 | MP0004947_skin_inflammation | 1.32923945 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.32451788 |
| 55 | MP0001849_ear_inflammation | 1.32085495 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.29500427 |
| 57 | MP0005166_decreased_susceptibility_to | 1.29267431 |
| 58 | MP0003279_aneurysm | 1.29124584 |
| 59 | MP0001835_abnormal_antigen_presentation | 1.28897432 |
| 60 | MP0003633_abnormal_nervous_system | 1.28041065 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 1.26457140 |
| 62 | MP0004270_analgesia | 1.25006894 |
| 63 | MP0005535_abnormal_body_temperature | 1.24326454 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.24247241 |
| 65 | MP0005671_abnormal_response_to | 1.23676547 |
| 66 | MP0002572_abnormal_emotion/affect_behav | 1.23124384 |
| 67 | MP0006054_spinal_hemorrhage | 1.22922856 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.22683012 |
| 69 | MP0005332_abnormal_amino_acid | 1.21971068 |
| 70 | MP0003091_abnormal_cell_migration | 1.20976068 |
| 71 | MP0001533_abnormal_skeleton_physiology | 1.20166592 |
| 72 | MP0010386_abnormal_urinary_bladder | 1.16912706 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.16032093 |
| 74 | MP0000920_abnormal_myelination | 1.14742578 |
| 75 | MP0002723_abnormal_immune_serum | 1.14705890 |
| 76 | MP0005023_abnormal_wound_healing | 1.14425045 |
| 77 | MP0008469_abnormal_protein_level | 1.06555059 |
| 78 | MP0005165_increased_susceptibility_to | 1.04592095 |
| 79 | MP0004130_abnormal_muscle_cell | 1.04297644 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 1.03924216 |
| 81 | MP0001545_abnormal_hematopoietic_system | 1.03924216 |
| 82 | MP0001486_abnormal_startle_reflex | 1.03751125 |
| 83 | MP0000609_abnormal_liver_physiology | 1.03630530 |
| 84 | MP0005164_abnormal_response_to | 1.02977757 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 1.02289810 |
| 86 | * MP0003634_abnormal_glial_cell | 1.01361880 |
| 87 | MP0003828_pulmonary_edema | 1.00997765 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00930738 |
| 89 | MP0002735_abnormal_chemical_nociception | 1.00820228 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.99749221 |
| 91 | MP0001440_abnormal_grooming_behavior | 0.99045167 |
| 92 | MP0005646_abnormal_pituitary_gland | 0.98852355 |
| 93 | MP0001666_abnormal_nutrient_absorption | 0.98303445 |
| 94 | MP0002733_abnormal_thermal_nociception | 0.96988333 |
| 95 | MP0002734_abnormal_mechanical_nocicepti | 0.96553642 |
| 96 | MP0001542_abnormal_bone_strength | 0.96056654 |
| 97 | MP0002148_abnormal_hypersensitivity_rea | 0.95954196 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 0.95054255 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.94918875 |
| 100 | MP0004883_abnormal_blood_vessel | 0.94913287 |
| 101 | MP0005310_abnormal_salivary_gland | 0.94820896 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.94535188 |
| 103 | MP0003631_nervous_system_phenotype | 0.94115922 |
| 104 | MP0009785_altered_susceptibility_to | 0.94102288 |
| 105 | MP0002067_abnormal_sensory_capabilities | 0.93805009 |
| 106 | MP0002405_respiratory_system_inflammati | 0.93515745 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.92011785 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.91451388 |
| 109 | MP0003879_abnormal_hair_cell | 0.90627998 |
| 110 | MP0001819_abnormal_immune_cell | 0.90404494 |
| 111 | MP0005000_abnormal_immune_tolerance | 0.89001579 |
| 112 | MP0002420_abnormal_adaptive_immunity | 0.88916613 |
| 113 | MP0001800_abnormal_humoral_immune | 0.88558900 |
| 114 | MP0002272_abnormal_nervous_system | 0.87056303 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.86849224 |
| 116 | MP0008874_decreased_physiological_sensi | 0.86322700 |
| 117 | MP0005025_abnormal_response_to | 0.86037939 |
| 118 | MP0005390_skeleton_phenotype | 0.85458028 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.85156502 |
| 120 | MP0008004_abnormal_stomach_pH | 0.83684091 |
| 121 | MP0000343_altered_response_to | 0.82136229 |
| 122 | MP0004019_abnormal_vitamin_homeostasis | 0.81316522 |
| 123 | MP0001970_abnormal_pain_threshold | 0.81282657 |
| 124 | MP0000249_abnormal_blood_vessel | 0.79203134 |
| 125 | * MP0002896_abnormal_bone_mineralization | 0.78821183 |
| 126 | MP0003045_fibrosis | 0.78558618 |
| 127 | * MP0003795_abnormal_bone_structure | 0.77975520 |
| 128 | MP0002254_reproductive_system_inflammat | 0.77907397 |
| 129 | MP0001958_emphysema | 0.75790557 |
| 130 | MP0002138_abnormal_hepatobiliary_system | 0.75774055 |
| 131 | MP0006276_abnormal_autonomic_nervous | 0.74567764 |
| 132 | MP0001502_abnormal_circadian_rhythm | 0.74396386 |
| 133 | MP0005595_abnormal_vascular_smooth | 0.73372818 |
| 134 | MP0002557_abnormal_social/conspecific_i | 0.72909104 |
| 135 | MP0009763_increased_sensitivity_to | 0.72656801 |
| 136 | MP0002229_neurodegeneration | 0.72552786 |
| 137 | MP0003632_abnormal_nervous_system | 0.71261466 |
| 138 | MP0008438_abnormal_cutaneous_collagen | 0.70005346 |
| 139 | MP0001790_abnormal_immune_system | 0.68561179 |
| 140 | MP0005387_immune_system_phenotype | 0.68561179 |
| 141 | MP0002078_abnormal_glucose_homeostasis | 0.68355255 |
| 142 | MP0002277_abnormal_respiratory_mucosa | 0.68185843 |
| 143 | MP0004924_abnormal_behavior | 0.66584437 |
| 144 | MP0002933_joint_inflammation | 0.65307291 |
| 145 | MP0004185_abnormal_adipocyte_glucose | 0.63005580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.85327779 |
| 2 | Complement deficiency (HP:0004431) | 5.24681304 |
| 3 | Glomerulonephritis (HP:0000099) | 4.85307038 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 4.55541242 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.47334938 |
| 6 | Abnormality of complement system (HP:0005339) | 4.07337962 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.05961671 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.86338282 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.86338282 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.86338282 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.55250515 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.54552946 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.50050577 |
| 14 | Deep venous thrombosis (HP:0002625) | 3.32672331 |
| 15 | Nuclear cataract (HP:0100018) | 3.27254704 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.21770068 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.16406805 |
| 18 | Joint hemorrhage (HP:0005261) | 3.10505609 |
| 19 | Xanthomatosis (HP:0000991) | 3.07798190 |
| 20 | Vertebral compression fractures (HP:0002953) | 3.06703623 |
| 21 | Amyloidosis (HP:0011034) | 2.99783217 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 2.94361706 |
| 23 | Purpura (HP:0000979) | 2.93822377 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.93225354 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.93225354 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.93225354 |
| 27 | Eczematoid dermatitis (HP:0000976) | 2.92854203 |
| 28 | Supranuclear gaze palsy (HP:0000605) | 2.92329918 |
| 29 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.87573167 |
| 30 | Axonal loss (HP:0003447) | 2.87307807 |
| 31 | Mucopolysacchariduria (HP:0008155) | 2.85419489 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.85419489 |
| 33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.84186841 |
| 34 | Hyperlipoproteinemia (HP:0010980) | 2.83920186 |
| 35 | Focal motor seizures (HP:0011153) | 2.80551903 |
| 36 | Nephritis (HP:0000123) | 2.77243587 |
| 37 | Apathy (HP:0000741) | 2.69987214 |
| 38 | Retinal atrophy (HP:0001105) | 2.68350102 |
| 39 | Diminished motivation (HP:0000745) | 2.68216457 |
| 40 | Myocardial infarction (HP:0001658) | 2.67364740 |
| 41 | Abnormality of macrophages (HP:0004311) | 2.56476448 |
| 42 | Abnormality of the common coagulation pathway (HP:0010990) | 2.53887075 |
| 43 | Epidermoid cyst (HP:0200040) | 2.50589171 |
| 44 | Progressive neurologic deterioration (HP:0002344) | 2.48782980 |
| 45 | Cerebral inclusion bodies (HP:0100314) | 2.48341692 |
| 46 | Intrahepatic cholestasis (HP:0001406) | 2.43242726 |
| 47 | Thin bony cortex (HP:0002753) | 2.42420361 |
| 48 | Prolonged neonatal jaundice (HP:0006579) | 2.39883332 |
| 49 | Mitral stenosis (HP:0001718) | 2.37958900 |
| 50 | Increased serum ferritin (HP:0003281) | 2.37852096 |
| 51 | Skin nodule (HP:0200036) | 2.36228930 |
| 52 | Upper motor neuron abnormality (HP:0002127) | 2.32631099 |
| 53 | Focal seizures (HP:0007359) | 2.32355147 |
| 54 | Asymmetric septal hypertrophy (HP:0001670) | 2.31518807 |
| 55 | Malnutrition (HP:0004395) | 2.30771021 |
| 56 | Bone pain (HP:0002653) | 2.30029057 |
| 57 | Neuronal loss in central nervous system (HP:0002529) | 2.28070015 |
| 58 | Mutism (HP:0002300) | 2.27705783 |
| 59 | Atonic seizures (HP:0010819) | 2.26630888 |
| 60 | Metaphyseal irregularity (HP:0003025) | 2.25343887 |
| 61 | Conjugated hyperbilirubinemia (HP:0002908) | 2.25048163 |
| 62 | Hypercholesterolemia (HP:0003124) | 2.24120221 |
| 63 | Status epilepticus (HP:0002133) | 2.22255371 |
| 64 | Generalized tonic-clonic seizures (HP:0002069) | 2.18480708 |
| 65 | Hypoalphalipoproteinemia (HP:0003233) | 2.17453701 |
| 66 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.15287012 |
| 67 | Absence seizures (HP:0002121) | 2.11191807 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.10667461 |
| 69 | Hemorrhage of the eye (HP:0011885) | 2.09384867 |
| 70 | Gingivitis (HP:0000230) | 2.09085002 |
| 71 | Blue irides (HP:0000635) | 2.08499982 |
| 72 | Febrile seizures (HP:0002373) | 2.08093137 |
| 73 | Protuberant abdomen (HP:0001538) | 2.07950267 |
| 74 | Turricephaly (HP:0000262) | 2.07292292 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.05929111 |
| 76 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05001884 |
| 77 | Loss of speech (HP:0002371) | 2.04229393 |
| 78 | Hepatosplenomegaly (HP:0001433) | 2.03318734 |
| 79 | Ketosis (HP:0001946) | 2.02879302 |
| 80 | Recurrent skin infections (HP:0001581) | 2.02777686 |
| 81 | Thoracic kyphosis (HP:0002942) | 2.02394177 |
| 82 | Joint stiffness (HP:0001387) | 2.00049184 |
| 83 | Clumsiness (HP:0002312) | 1.98885963 |
| 84 | Hyperventilation (HP:0002883) | 1.98787443 |
| 85 | Premature rupture of membranes (HP:0001788) | 1.98473206 |
| 86 | Dialeptic seizures (HP:0011146) | 1.96510984 |
| 87 | J-shaped sella turcica (HP:0002680) | 1.95782315 |
| 88 | Achilles tendon contracture (HP:0001771) | 1.95249539 |
| 89 | Thick nail (HP:0001805) | 1.95147718 |
| 90 | Epileptic encephalopathy (HP:0200134) | 1.94383051 |
| 91 | Abnormality of the Achilles tendon (HP:0005109) | 1.93498714 |
| 92 | Personality changes (HP:0000751) | 1.92764793 |
| 93 | Cardiomegaly (HP:0001640) | 1.92589617 |
| 94 | Action tremor (HP:0002345) | 1.91377596 |
| 95 | Hypophosphatemia (HP:0002148) | 1.86898901 |
| 96 | Visual hallucinations (HP:0002367) | 1.86747882 |
| 97 | Progressive visual loss (HP:0000529) | 1.86331450 |
| 98 | Cervical subluxation (HP:0003308) | 1.86044365 |
| 99 | Diplopia (HP:0000651) | 1.85656053 |
| 100 | Abnormality of binocular vision (HP:0011514) | 1.85656053 |
| 101 | Arterial tortuosity (HP:0005116) | 1.85599959 |
| 102 | Hypolipoproteinemia (HP:0010981) | 1.83545980 |
| 103 | Autoimmune thrombocytopenia (HP:0001973) | 1.82505444 |
| 104 | Upper limb amyotrophy (HP:0009129) | 1.82453447 |
| 105 | Distal upper limb amyotrophy (HP:0007149) | 1.82453447 |
| 106 | Mesangial abnormality (HP:0001966) | 1.81386118 |
| 107 | Hypobetalipoproteinemia (HP:0003563) | 1.80676499 |
| 108 | Elevated alkaline phosphatase (HP:0003155) | 1.80363533 |
| 109 | Peripheral demyelination (HP:0011096) | 1.79844545 |
| 110 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.79435737 |
| 111 | Sensorimotor neuropathy (HP:0007141) | 1.79127185 |
| 112 | Petechiae (HP:0000967) | 1.77525872 |
| 113 | Global brain atrophy (HP:0002283) | 1.77410737 |
| 114 | Abnormality of iron homeostasis (HP:0011031) | 1.77244794 |
| 115 | Agitation (HP:0000713) | 1.74043017 |
| 116 | Excessive salivation (HP:0003781) | 1.73602960 |
| 117 | Drooling (HP:0002307) | 1.73602960 |
| 118 | Myokymia (HP:0002411) | 1.71796154 |
| 119 | Polyphagia (HP:0002591) | 1.71421744 |
| 120 | Gingival bleeding (HP:0000225) | 1.70844350 |
| 121 | Distal lower limb muscle weakness (HP:0009053) | 1.70809913 |
| 122 | Chronic obstructive pulmonary disease (HP:0006510) | 1.70358101 |
| 123 | Obstructive lung disease (HP:0006536) | 1.70358101 |
| 124 | Ovoid vertebral bodies (HP:0003300) | 1.69994977 |
| 125 | Orchitis (HP:0100796) | 1.69102627 |
| 126 | Hyperparathyroidism (HP:0000843) | 1.68741739 |
| 127 | Fair hair (HP:0002286) | 1.68443500 |
| 128 | Disinhibition (HP:0000734) | 1.68068720 |
| 129 | Ketoacidosis (HP:0001993) | 1.67586491 |
| 130 | Cerebral aneurysm (HP:0004944) | 1.66434331 |
| 131 | Nausea (HP:0002018) | 1.65448270 |
| 132 | Zonular cataract (HP:0010920) | 1.65316870 |
| 133 | Pathologic fracture (HP:0002756) | 1.64656805 |
| 134 | Abnormality of the nasal mucosa (HP:0000433) | 1.64414434 |
| 135 | Torticollis (HP:0000473) | 1.61998017 |
| 136 | Vascular tortuosity (HP:0004948) | 1.61675242 |
| 137 | Abnormality of the thoracic spine (HP:0100711) | 1.60494702 |
| 138 | Mediastinal lymphadenopathy (HP:0100721) | 1.60409678 |
| 139 | Abnormality of the periventricular white matter (HP:0002518) | 1.60363163 |
| 140 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.59594820 |
| 141 | Myositis (HP:0100614) | 1.59306247 |
| 142 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.58895087 |
| 143 | Dementia (HP:0000726) | 1.58716063 |
| 144 | Abnormal eating behavior (HP:0100738) | 1.58555778 |
| 145 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.58499186 |
| 146 | Spontaneous abortion (HP:0005268) | 1.58405026 |
| 147 | Hand muscle atrophy (HP:0009130) | 1.58060617 |
| 148 | Progressive cerebellar ataxia (HP:0002073) | 1.57905602 |
| 149 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.57224293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.69351848 |
| 2 | RIPK4 | 3.12534424 |
| 3 | TESK1 | 2.90964005 |
| 4 | DDR2 | 2.62206370 |
| 5 | TESK2 | 2.54414048 |
| 6 | MAP3K11 | 2.38726540 |
| 7 | TAOK2 | 2.32722433 |
| 8 | NTRK3 | 2.19834579 |
| 9 | MAP2K4 | 2.13913845 |
| 10 | CAMK1G | 2.06178386 |
| 11 | MAP3K9 | 2.05249146 |
| 12 | EPHA4 | 1.99376536 |
| 13 | PIM2 | 1.90217095 |
| 14 | BLK | 1.89370841 |
| 15 | INSRR | 1.82220955 |
| 16 | IRAK4 | 1.75660511 |
| 17 | LIMK1 | 1.73385237 |
| 18 | ERN1 | 1.72831169 |
| 19 | TAOK3 | 1.72098834 |
| 20 | MAP3K14 | 1.67097383 |
| 21 | MAP3K3 | 1.66613457 |
| 22 | TYK2 | 1.63681509 |
| 23 | DAPK2 | 1.62062372 |
| 24 | MAP3K4 | 1.60072378 |
| 25 | TAOK1 | 1.59962810 |
| 26 | JAK1 | 1.54932013 |
| 27 | CDC42BPA | 1.54175049 |
| 28 | CAMK1D | 1.51751266 |
| 29 | MAP2K7 | 1.50803728 |
| 30 | FES | 1.49622243 |
| 31 | EPHB2 | 1.48438609 |
| 32 | TGFBR2 | 1.47117092 |
| 33 | FGR | 1.45065034 |
| 34 | PRPF4B | 1.43278294 |
| 35 | CASK | 1.42843904 |
| 36 | PAK4 | 1.42251089 |
| 37 | MINK1 | 1.41348120 |
| 38 | RIPK1 | 1.35080282 |
| 39 | PDGFRA | 1.30953598 |
| 40 | GRK7 | 1.29946482 |
| 41 | MAP3K13 | 1.27646254 |
| 42 | NTRK1 | 1.26501952 |
| 43 | BMPR2 | 1.26354127 |
| 44 | ICK | 1.24186992 |
| 45 | TBK1 | 1.23641466 |
| 46 | MAP2K3 | 1.23604414 |
| 47 | EPHB1 | 1.22432120 |
| 48 | MARK1 | 1.20638378 |
| 49 | IRAK2 | 1.16172472 |
| 50 | MOS | 1.15606665 |
| 51 | IRAK3 | 1.12052388 |
| 52 | NEK9 | 1.11654784 |
| 53 | KIT | 1.10648181 |
| 54 | SIK2 | 1.10423698 |
| 55 | PAK6 | 1.09268702 |
| 56 | TXK | 1.06547023 |
| 57 | TTN | 1.06371568 |
| 58 | CAMKK1 | 1.06312711 |
| 59 | KSR2 | 0.97913760 |
| 60 | PLK2 | 0.97398654 |
| 61 | IKBKE | 0.96911322 |
| 62 | MAP3K6 | 0.96235920 |
| 63 | EPHA2 | 0.96234478 |
| 64 | SIK1 | 0.94814953 |
| 65 | CAMKK2 | 0.94349882 |
| 66 | SGK3 | 0.92588639 |
| 67 | MAP3K1 | 0.91909556 |
| 68 | SGK2 | 0.91241878 |
| 69 | PDPK1 | 0.91161383 |
| 70 | CSK | 0.85561488 |
| 71 | MAP4K1 | 0.81778753 |
| 72 | HCK | 0.81750287 |
| 73 | PRKCH | 0.81395265 |
| 74 | SGK223 | 0.80770844 |
| 75 | SGK494 | 0.80770844 |
| 76 | CSF1R | 0.80767074 |
| 77 | NTRK2 | 0.80411346 |
| 78 | JAK2 | 0.80089310 |
| 79 | SMG1 | 0.79586351 |
| 80 | IKBKB | 0.79255063 |
| 81 | JAK3 | 0.78801830 |
| 82 | FGFR4 | 0.78592344 |
| 83 | MATK | 0.78295090 |
| 84 | MAPK12 | 0.77133132 |
| 85 | SIK3 | 0.76018514 |
| 86 | PRKCE | 0.74928733 |
| 87 | BMX | 0.74217815 |
| 88 | IRAK1 | 0.72193492 |
| 89 | CDK5 | 0.72118101 |
| 90 | PHKG2 | 0.71443909 |
| 91 | PHKG1 | 0.71443909 |
| 92 | TRIB3 | 0.71245553 |
| 93 | PDK1 | 0.70818814 |
| 94 | FYN | 0.70048151 |
| 95 | MAP3K12 | 0.69944027 |
| 96 | PRKCG | 0.69287574 |
| 97 | PRKG2 | 0.68698822 |
| 98 | MAP3K2 | 0.67219383 |
| 99 | PRKAA2 | 0.67106226 |
| 100 | MST1R | 0.66888145 |
| 101 | RET | 0.66210812 |
| 102 | MAPK15 | 0.65937742 |
| 103 | PKN1 | 0.65368195 |
| 104 | EPHA3 | 0.63690502 |
| 105 | TYRO3 | 0.62585506 |
| 106 | EGFR | 0.62073557 |
| 107 | ZAP70 | 0.61975213 |
| 108 | ERBB3 | 0.61874465 |
| 109 | SGK1 | 0.61848789 |
| 110 | MAP3K5 | 0.61657330 |
| 111 | LATS2 | 0.60123771 |
| 112 | PRKCZ | 0.59857167 |
| 113 | PKN2 | 0.59266137 |
| 114 | ARAF | 0.59214896 |
| 115 | DAPK3 | 0.58898266 |
| 116 | MAPK7 | 0.58582760 |
| 117 | PNCK | 0.56449893 |
| 118 | STK38 | 0.54967747 |
| 119 | ERBB4 | 0.54879633 |
| 120 | BCKDK | 0.54599917 |
| 121 | CAMK2A | 0.53765670 |
| 122 | LYN | 0.52967147 |
| 123 | PAK3 | 0.52755059 |
| 124 | PDK2 | 0.52686941 |
| 125 | KSR1 | 0.51617010 |
| 126 | PTK6 | 0.51165068 |
| 127 | MAPKAPK3 | 0.50955351 |
| 128 | ACVR1B | 0.50797770 |
| 129 | RPS6KC1 | 0.50312233 |
| 130 | RPS6KL1 | 0.50312233 |
| 131 | MARK2 | 0.49986446 |
| 132 | ABL2 | 0.49628753 |
| 133 | FGFR3 | 0.49413457 |
| 134 | IGF1R | 0.48203183 |
| 135 | ADRBK2 | 0.48107877 |
| 136 | KDR | 0.47917426 |
| 137 | PRKG1 | 0.47712356 |
| 138 | MAP2K6 | 0.47572206 |
| 139 | SYK | 0.47565074 |
| 140 | RPS6KA2 | 0.47230267 |
| 141 | CDK6 | 0.47059356 |
| 142 | CHUK | 0.46916028 |
| 143 | PRKD2 | 0.46170809 |
| 144 | GRK5 | 0.45847918 |
| 145 | NEK6 | 0.44499250 |
| 146 | CAMK4 | 0.44216435 |
| 147 | LMTK2 | 0.43745754 |
| 148 | PTK2 | 0.42974426 |
| 149 | CAMK2G | 0.41557853 |
| 150 | DYRK1B | 0.40715674 |
| 151 | MAP3K8 | 0.39890822 |
| 152 | MAPK4 | 0.38668537 |
| 153 | MAPK11 | 0.36389656 |
| 154 | PDGFRB | 0.33920251 |
| 155 | CDK15 | 0.33796753 |
| 156 | CDK14 | 0.32407647 |
| 157 | SRC | 0.31782306 |
| 158 | RPS6KA6 | 0.30588942 |
| 159 | PAK1 | 0.30587187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.39092742 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.84454922 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.64439984 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.32354619 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.19350991 |
| 6 | * Lysosome_Homo sapiens_hsa04142 | 1.78633156 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.74776202 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69356354 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 1.52263741 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.48788764 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.44862719 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42493332 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.37659088 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 1.36400417 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.36230134 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.35689326 |
| 17 | Prion diseases_Homo sapiens_hsa05020 | 1.35336662 |
| 18 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.32833975 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.26860510 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24677083 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.22259837 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22246031 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20965625 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.19027831 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.17295840 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16430887 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.16167334 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15868887 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14398966 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13091474 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12313887 |
| 32 | Mineral absorption_Homo sapiens_hsa04978 | 1.11066968 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.09960641 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.08364557 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.07565513 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07422978 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.07242218 |
| 38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.06822881 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.06696094 |
| 40 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05827800 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05436617 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04566932 |
| 43 | Bladder cancer_Homo sapiens_hsa05219 | 1.04411547 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.04340160 |
| 45 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.04288152 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.02134683 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99414567 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97744093 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95248876 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 0.95132749 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94544613 |
| 52 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.93983013 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.92912915 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88203328 |
| 55 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86387297 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86292792 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85771763 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85235292 |
| 59 | Morphine addiction_Homo sapiens_hsa05032 | 0.84917862 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 0.84853989 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84829979 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84715936 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.83756687 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.83472902 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.82953969 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82578524 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82357236 |
| 68 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.81210878 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80447378 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80238485 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80105665 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78730485 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78402459 |
| 74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78230046 |
| 75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77646730 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77505524 |
| 77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76853350 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.75162822 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74967157 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.73515967 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71879243 |
| 82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71484977 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.69881200 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69327462 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.67869676 |
| 86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67557262 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66269546 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65788282 |
| 89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64819208 |
| 90 | Malaria_Homo sapiens_hsa05144 | 0.63947973 |
| 91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62961615 |
| 92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62510099 |
| 93 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.62462889 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61956752 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61511889 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60620476 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.60124070 |
| 98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60119994 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58452844 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.57902184 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57266041 |
| 102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56935258 |
| 103 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55865978 |
| 104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55833833 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54364693 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54258979 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54157477 |
| 108 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.53298543 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53092917 |
| 110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52537099 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51764129 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51707805 |
| 113 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51613083 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50928871 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50747620 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50728415 |
| 117 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50677026 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50356652 |
| 119 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50316687 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50104253 |
| 121 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50002950 |
| 122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49985527 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48704531 |
| 124 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48156339 |
| 125 | Long-term depression_Homo sapiens_hsa04730 | 0.47519473 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47271020 |
| 127 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.46983279 |
| 128 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45977205 |
| 129 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45781726 |
| 130 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45473420 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45196032 |
| 132 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45085145 |
| 133 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44200811 |
| 134 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44168172 |
| 135 | Endocytosis_Homo sapiens_hsa04144 | 0.43974772 |
| 136 | Salmonella infection_Homo sapiens_hsa05132 | 0.43864574 |
| 137 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43682151 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43518276 |
| 139 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.43451312 |
| 140 | Taste transduction_Homo sapiens_hsa04742 | 0.42809054 |
| 141 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42600193 |
| 142 | Hepatitis B_Homo sapiens_hsa05161 | 0.42272353 |
| 143 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41579930 |
| 144 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41562231 |
| 145 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41061198 |
| 146 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40526809 |
| 147 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40248103 |
| 148 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39531254 |
| 149 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38881273 |
| 150 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38613332 |
| 151 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37744061 |
| 152 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36338387 |
| 153 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32926562 |
| 154 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32606350 |
| 155 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32155053 |

